Goldman Sachs’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.35M | Buy |
559,283
+157,519
| +39% | +$2.07M | ﹤0.01% | 2505 |
|
|
2025
Q1 | $5.78M | Buy |
401,764
+226,198
| +129% | +$3.25M | ﹤0.01% | 2635 |
|
|
2024
Q4 | $2.94M | Buy |
175,566
+162,511
| +1,245% | +$2.72M | ﹤0.01% | 3243 |
|
|
2024
Q3 | $209K | Buy |
+13,055
| New | +$209K | ﹤0.01% | 4475 |
|
|
2024
Q2 | – | Sell |
-55,027
| Closed | -$622K | – | 4758 |
|
|
2024
Q1 | $622K | Buy |
55,027
+30,296
| +123% | +$342K | ﹤0.01% | 3882 |
|
|
2023
Q4 | $197K | Buy |
24,731
+14,081
| +132% | +$112K | ﹤0.01% | 4334 |
|
|
2023
Q3 | $68.9K | Hold |
10,650
| – | – | ﹤0.01% | 4446 |
|
|
2023
Q2 | $65.9K | Sell |
10,650
-310
| -3% | -$1.92K | ﹤0.01% | 4633 |
|
|
2023
Q1 | $42.2K | Sell |
10,960
-4,033
| -27% | -$15.5K | ﹤0.01% | 4789 |
|
|
2022
Q4 | $46.5K | Sell |
14,993
-1,536
| -9% | -$4.76K | ﹤0.01% | 4800 |
|
|
2022
Q3 | $66K | Sell |
16,529
-14
| -0.1% | -$56 | ﹤0.01% | 5000 |
|
|
2022
Q2 | $81K | Buy |
+16,543
| New | +$81K | ﹤0.01% | 5175 |
|